AlphaYouKA
Insider selling
Kristin Abate sold $450 of Karyopharm Therapeutics Inc. (KPTI) stock
Kristin Abate, Chief Accounting Officer of Karyopharm Therapeutics Inc. (KPTI), sold 378 shares of KPTI stock worth $450, per an SEC Form 4 filed Oct 2, 2026.
It was an open-market sale.
The trade happened on Oct 1, 2026, 1 day before it was made public.
KPTI has moved -7.5% since the trade date, from $0.87 to $0.80 (Oct 2, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 2, 2026
- Filing delay
- 1 day
- Price since
- -7.5%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4
More KPTI insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.